Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS
Crossref DOI link: https://doi.org/10.1007/s00467-017-3612-9
Published Online: 2017-02-20
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hackl, Agnes
Ehren, Rasmus
Kirschfink, Michael
Zipfel, Peter F.
Beck, Bodo B.
Weber, Lutz T.
Habbig, Sandra http://orcid.org/0000-0002-6511-5023
License valid from 2017-02-20